Cargando…

Inclusion of participants from low-income and middle-income countries in core outcome sets development: a systematic review

OBJECTIVE: Our study aims to describe differences or similarities in the scope, participant characteristics and methods used in core outcome sets (COS) development when only participants from high-income countries (HICs) were involved compared with when participants from low-income and middle-income...

Descripción completa

Detalles Bibliográficos
Autores principales: Karumbi, Jamlick, Gorst, Sarah L, Gathara, David, Gargon, Elizabeth, Young, Bridget, Williamson, Paula R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527127/
https://www.ncbi.nlm.nih.gov/pubmed/34667005
http://dx.doi.org/10.1136/bmjopen-2021-049981
_version_ 1784586016280018944
author Karumbi, Jamlick
Gorst, Sarah L
Gathara, David
Gargon, Elizabeth
Young, Bridget
Williamson, Paula R
author_facet Karumbi, Jamlick
Gorst, Sarah L
Gathara, David
Gargon, Elizabeth
Young, Bridget
Williamson, Paula R
author_sort Karumbi, Jamlick
collection PubMed
description OBJECTIVE: Our study aims to describe differences or similarities in the scope, participant characteristics and methods used in core outcome sets (COS) development when only participants from high-income countries (HICs) were involved compared with when participants from low-income and middle-income countries (LMICs) were also involved. DESIGN: Systematic review. DATA SOURCES: Annual Core Outcome Measures in Effectiveness Trials systematic reviews of COS which are updated based on SCOPUS and MEDLINE, searches. The latest systematic review included studies published up to the end of 2019. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: We included studies reporting development of a COS for use in research regardless of age, health condition or setting. Studies reporting the development of a COS for patient-reported outcomes or adverse events or complications were also included. DATA EXTRACTION AND SYNTHESIS: Data were extracted in relation to scope of the COS study, participant categories and the methods used in outcome selection. RESULTS: Studies describing 370 COS were identified in the database. Of these, 75 (20%) included participants from LMICs. Only four COS were initiated from an LMIC setting. More than half of COS with LMIC participants were developed in the last 5 years. Cancer and rheumatology were the dominant disease domains. Overall, over 259 (70%) of COS explicitly reported including clinical experts; this was higher where LMIC participants were also included 340 (92%). Most LMIC participants were from China, Brazil and South Africa. Mixed methods for consensus building were used across the two settings. CONCLUSION: Progress has been made in including LMIC participants in the development of COS, however, there is a need to explore how to enable initiation of COS development from a range of LMIC settings, how to ensure prioritisation of COS that better reflects the burden of disease in these contexts and how to improve public participation from LMICs.
format Online
Article
Text
id pubmed-8527127
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-85271272021-11-04 Inclusion of participants from low-income and middle-income countries in core outcome sets development: a systematic review Karumbi, Jamlick Gorst, Sarah L Gathara, David Gargon, Elizabeth Young, Bridget Williamson, Paula R BMJ Open Epidemiology OBJECTIVE: Our study aims to describe differences or similarities in the scope, participant characteristics and methods used in core outcome sets (COS) development when only participants from high-income countries (HICs) were involved compared with when participants from low-income and middle-income countries (LMICs) were also involved. DESIGN: Systematic review. DATA SOURCES: Annual Core Outcome Measures in Effectiveness Trials systematic reviews of COS which are updated based on SCOPUS and MEDLINE, searches. The latest systematic review included studies published up to the end of 2019. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: We included studies reporting development of a COS for use in research regardless of age, health condition or setting. Studies reporting the development of a COS for patient-reported outcomes or adverse events or complications were also included. DATA EXTRACTION AND SYNTHESIS: Data were extracted in relation to scope of the COS study, participant categories and the methods used in outcome selection. RESULTS: Studies describing 370 COS were identified in the database. Of these, 75 (20%) included participants from LMICs. Only four COS were initiated from an LMIC setting. More than half of COS with LMIC participants were developed in the last 5 years. Cancer and rheumatology were the dominant disease domains. Overall, over 259 (70%) of COS explicitly reported including clinical experts; this was higher where LMIC participants were also included 340 (92%). Most LMIC participants were from China, Brazil and South Africa. Mixed methods for consensus building were used across the two settings. CONCLUSION: Progress has been made in including LMIC participants in the development of COS, however, there is a need to explore how to enable initiation of COS development from a range of LMIC settings, how to ensure prioritisation of COS that better reflects the burden of disease in these contexts and how to improve public participation from LMICs. BMJ Publishing Group 2021-10-18 /pmc/articles/PMC8527127/ /pubmed/34667005 http://dx.doi.org/10.1136/bmjopen-2021-049981 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Epidemiology
Karumbi, Jamlick
Gorst, Sarah L
Gathara, David
Gargon, Elizabeth
Young, Bridget
Williamson, Paula R
Inclusion of participants from low-income and middle-income countries in core outcome sets development: a systematic review
title Inclusion of participants from low-income and middle-income countries in core outcome sets development: a systematic review
title_full Inclusion of participants from low-income and middle-income countries in core outcome sets development: a systematic review
title_fullStr Inclusion of participants from low-income and middle-income countries in core outcome sets development: a systematic review
title_full_unstemmed Inclusion of participants from low-income and middle-income countries in core outcome sets development: a systematic review
title_short Inclusion of participants from low-income and middle-income countries in core outcome sets development: a systematic review
title_sort inclusion of participants from low-income and middle-income countries in core outcome sets development: a systematic review
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527127/
https://www.ncbi.nlm.nih.gov/pubmed/34667005
http://dx.doi.org/10.1136/bmjopen-2021-049981
work_keys_str_mv AT karumbijamlick inclusionofparticipantsfromlowincomeandmiddleincomecountriesincoreoutcomesetsdevelopmentasystematicreview
AT gorstsarahl inclusionofparticipantsfromlowincomeandmiddleincomecountriesincoreoutcomesetsdevelopmentasystematicreview
AT gatharadavid inclusionofparticipantsfromlowincomeandmiddleincomecountriesincoreoutcomesetsdevelopmentasystematicreview
AT gargonelizabeth inclusionofparticipantsfromlowincomeandmiddleincomecountriesincoreoutcomesetsdevelopmentasystematicreview
AT youngbridget inclusionofparticipantsfromlowincomeandmiddleincomecountriesincoreoutcomesetsdevelopmentasystematicreview
AT williamsonpaular inclusionofparticipantsfromlowincomeandmiddleincomecountriesincoreoutcomesetsdevelopmentasystematicreview